Facial Injectables Market Size & Share, by Product (Collagen, Hyaluronic Acid [HA], Botulinum Toxin Type A, Calcium Hydroxylapatite [CaHA], Polymer Fillers); Application (Wrinkle Reduction, Facelift, Acne Scar Treatment, Lipoatrophy Treatment, Lip Enhancement); End-user (Hospitals, Specialty Clinics, Dermatology & Beauty Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

Growth Drivers

• Growing Income Level of the Population - It is predicted that people tend to spend more when their income level is high. Thus, people have started spending more on cosmetic procedures and beauty products to reach the beauty standards set by society. As facial injectable carries huge price the increased level of income is expected to make it easier for people to spend more on this treatment. Hence, this factor is expected to drive the growth of the facial injectables market. Up from roughly 90 million households across the globe in 2019, it was predicted that 130 million families had an annual income of between USD 3,000 and USD 9,000 by 2022.
• Growing Geriatric Population – With aging, the skin of the human body starts to deteriorate which gives birth to fine lines, dark spots, wrinkles, and other skin problems. Thus, for treating such problems, facial injectables are known to be very effective. Hence, the burgeoning geriatric population is projected to increase the sales of facial injectables in the forecast period. According to the World Health Organization, one in six persons in the world would be 60 years of age or older by the year 2030.
• Increasing Proportion of Male Populace – The male population of the world has been adopting several types of facial injectables such as botulinum toxin and dermal fillers to reduce the possibility of developing new lines, creases, and folds by plumping up the skin and adding volume. Thus, the growing male population is anticipated to bring lucrative growth opportunities for market growth. The population of the world had almost 40 million more men than women as of 2021.
• New Product Launch in the field of Facial Injectables - To treat moderate to severe facial creases and folds, including nasolabial folds, the U.S. Food and Drug Administration ("FDA") approved EVOLENCE. New structural dermal filler EVOLENCE, a first of its type, is based on innovative collagen technology.
• Growing Preference Towards Minimally Invasive Procedures - Long-term results, the surgeon's recommendations, and the probability of complications were recognized by worldwide patients as being the most important considerations when choosing between open and MIS surgery, according to the NCBI. Patients around the world preferred MIS surgery as it was superior to open surgery in terms of postoperative discomfort, complication risk, recovery time, cost, and the requirement for anesthesia. The majority of patients seem to prefer minimally intrusive forms of therapy.

Challenges

• Side Effects Associated with Dermal Injectables – Facial or dermal injectors lead to various side effects including bruising, scarring, and swelling. In some cases, it might also cause a bluish discoloration of the skin overlaying the filer. Hence, this factor is expected to hinder the growth of the facial injectables market.
• High Cost Attributed to these Procedures
• Lack of Reimbursement Policies